Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
04 February 2022
Closing Date:
04 March 2022
Location(s):
BE BELGIQUE-BELGIË (BE Belgium/BELGIQUE-BELGIË)
Description:
Fulvestrant

The contract concerns supplies of the pharmaceutical specialty containing the active ingredient “Fulvestrant” in solution for injection intramuscularly. The pharmaceutical specialty is supplied in a pre-filled syringe containing 250 mg of active ingredient in 5 ml of solution.

The contract concerns supplies of the pharmaceutical specialty containing the active ingredient “Fulvestrant” in solution for injection intramuscularly. The pharmaceutical specialty is supplied in a pre-filled syringe containing 250 mg of active ingredient in 5 ml of solution.

Download full details as .pdf
The Buyer:
Cliniques universitaires Saint-Luc
CPV Code(s):
33600000 - Pharmaceutical products